How to Best Prepare for Final DSCSA Deadlines
Gary Lerner
Founder and President at Gateway Checker Corporation Managing Director at BrandSure, LLC
As highlighted numerous times since its announcement, the FDA has provided an exemption for certain eligible trading partners from Enhanced Drug Distribution Security (EDDS) Requirements of the Drug Supply Chain Security Act (DSCSA). These exemptions vary in length depending on the trade partner; for manufacturers and repackagers, the deadline for compliance is May 27th, 2025... less than four short months away. For other types of eligible trading partners, the deadlines come shortly after.?
Tracy Nasarenko, Vice President of Consumer Success (Healthcare) at GS1 US, recently published an article emphasizing the importance of data quality for adherence to DSCSA guidelines. If a trading partner has missing/incorrect information in their master data (i.e. GLNs or GTINs), exceptions and possible quarantines could be the result; situations like this may prevent patients from receiving necessary medications.?
Recall that potential supply chain delays were the main reason the FDA implemented the stabilization period (as well as the recent October 10th exemption) in the first place. The FDA was concerned that with not enough trading partners prepared to send and receive interoperable data, extensive product and data delays could inhibit millions of patients from receiving medications in a timely manner.?
However, following numerous delays and exemptions, its more than likely the May 27th deadline for manufacturers and repackagers will remain in stone. Additionally, given how much time has been allotted for trade partners to prepare their systems and meet DSCSA requirements, not as much leeway will be given by the FDA for those who aren’t ready.??
While adhering to the requirements of the DSCSA may seem a bit overwhelming, here's a few tips that will help simplify the process:?
Learning Specialist at Charles E Smith Jewish Day School
4 周Very informative
President & Chief Operating Officer & Board Member- Power Saudia, Inc.
1 个月Great insights, Gary! Your article highlights the critical steps trading partners need to take to meet the final DSCSA deadlines effectively. The importance of understanding the law and exemptions, ensuring system interoperability, and proactive testing cannot be overstated. With less than four months to go, timely compliance is crucial to avoid supply chain disruptions and ensure patients receive their medications without delay. Thank you for emphasizing the value of communication and the role of Gateway Checker's GS1 Certified Conformance Testing Service in addressing conformance and interoperability issues. It's essential that all trading partners stay ahead of the curve and not wait until the last minute. Excellent points all around!
COO | Senior VP | Business Development & Partnerships | Product Strategist | Consultant
1 个月Great insight and advice!